🟠 Celltrion's CT-P41 biosimilar is still awaiting FDA approval, with plans to launch in Korea in early 2025. #glp1 #obesity #weightloss $LLY #Zepbound #biopharma #ozempic $NVO $vktx $zeal $tern $alt @FDA
#glp1 #obesity #weightloss #LLY #Zepbound #biopharma #ozempic #NVO #vktx #zeal #tern #alt